Evaluation of the retinal electrofisiological response in patients with compensated GLAUCOMA POAG in treatment with epigallocatechin-gallate Epinerve . - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2007年1月30日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•INCLUSION CRITERIA IN OHT PATIENTS 61623; IOP 21 mm Hg in two separate occasions at diagnosis. 61623; IOP steady at least in the last three months. 61623; Optic nerve head with normal morphology in stereoscopic evaluation performed with biomicroscopy and 78D lens. 61623; Standard automated perimetry Humphrey 30-2 SITA Standard test within normal limits. 61623; Alteration of PERG. 61623; Familiarity for glaucoma INCLUSION CRITERIA IN EOAG PATIENT 61623; IOP 21 mm Hg in two separate occasions at diagnosis. 61623; IOP steady at least in the last three months. 61623; Optic nerve head with normal morphology in stereoscopic evaluation performed with biomicroscopy and 78D lens. 61623; Standard automated perimetry Humphrey 30-2 SITA Standard test out of normal limits.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•61623; Therapy change. 61623; Smokers. 61623; Antecedent ocular surgeries. 61623; Concomitant ocular or systemic diseases.

发起方

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI